Trial Profile
A Multi-Institution Phase II Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pralatrexate (Primary) ; Cobalamin; Folic acid
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 09 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Apr 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 22 Apr 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.